These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10078)

  • 1. Nonenzymatic reduction of benzo(a)pyrene diol-epoxides to trihydroxypentahydrobenzo(a)pyrenes by reduced nicotinamide adenine dinucleotide phosphate.
    Yang SK; Gelboin HV
    Cancer Res; 1976 Nov; 36(11 Pt 1):4185-9. PubMed ID: 10078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic conversion of benzo(a)pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene through a single enantiomer of r-7, t-8-dihydroxy-7,8-dihydrobenzo(a)pyrene.
    Yang SK; McCourt DW; Roller PP; Gelboin HV
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2594-8. PubMed ID: 1066669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.
    Kapitulnik J; Wislocki PG; Levin W; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1978 Feb; 38(2):354-8. PubMed ID: 620406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral stationary phase high-performance liquid chromatographic resolution and absolute configuration of enantiomeric benzo[a]pyrene diol-epoxides and tetrols.
    Weems HB; Yang SK
    Chirality; 1989; 1(4):276-83. PubMed ID: 2642055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of benzo(a)pyrene and binding to DNA in cultured human bronchus.
    Yang SK; Gelboin HV; Trump BF; Autrup H; Harris CC
    Cancer Res; 1977 Apr; 37(4):1210-5. PubMed ID: 844046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
    Chiu PL; Yang SK
    Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene by mouse lung microsomes.
    Sydor W; Lewis KF; Yang CS
    Cancer Res; 1984 Jan; 44(1):134-8. PubMed ID: 6317167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of anti-7,8-dihydroxy-9,10-epoxy-7,8,9, 10-tetrahydro-11-methylbenzo[a]pyrene and its reaction with DNA.
    Lin JM; Desai D; Chung L; Hecht SS; Amin S
    Chem Res Toxicol; 1999 Apr; 12(4):341-6. PubMed ID: 10207123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenicity of the diastereomeric bay-region benzo(e)pyrene 9,10-diol-11,12-epoxides in newborn mice.
    Chang RL; Levin W; Wood AW; Lehr RE; Kumar S; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1981 Mar; 41(3):915-8. PubMed ID: 7459878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal oxidation of (+/-)-9,10-dihydroxy-9,10-dihydrobenzo[a]pyrene: formation of diastereomeric benzo[a]pyrene 9,10-diol 7,8-epoxides.
    Cerniglia CE; Gibson DT
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4554-8. PubMed ID: 6933504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides.
    Thakker DR; Yagi H; Lu AY; Levin W; Conney AH
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3381-5. PubMed ID: 1068451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of DNA and globin adducts of polynuclear aromatic hydrocarbon diol epoxides by gas chromatography-mass spectrometry and -3H-CH3I postlabeling of released tetraols.
    Melikian AA; Sun P; Coleman S; Amin S; Hecht SS
    Chem Res Toxicol; 1996 Mar; 9(2):508-16. PubMed ID: 8839056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of enantiomers of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]-pyrene in human urine: evidence supporting metabolic activation of benzo[a]pyrene via the bay region diol epoxide.
    Hecht SS; Hochalter JB
    Mutagenesis; 2014 Sep; 29(5):351-6. PubMed ID: 25053834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal hyperplasia after topical application of benzo (a) pyrene, benzo (a) pyrene diol epoxides, and other metabolites.
    Bresnick E; McDonald TF; Yagi H; Jerina DM; Levin W; Wood AW; Conney AH
    Cancer Res; 1977 Apr; 37(4):984-90. PubMed ID: 844052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene.
    Hecht SS; el-Bayoumy K; Rivenson A; Amin S
    Cancer Res; 1994 Jan; 54(1):21-4. PubMed ID: 8261440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.